Physician profile
Ben Ho Park
NPI 1407896509
$25,288.48
in general payments reported to CMS, 2019-2025
12 companies · $14K in 2025
The $14K reported for 2025 was more than what 91% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $39.91 · 2021: $7,100 · 2022: $620 · 2023: $3,675 · 2024: $41.55 · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Consulting Fee: $6,020 · Travel and Lodging: $513 · Food and Beverage: $196.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,800.00 |
| Consulting Fee | $6,020.00 |
| Travel and Lodging | $512.95 |
| Food and Beverage | $195.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $10,800.00 | 2025 | Verzenio |
| Focal Therapeutics, INC. | $3,375.00 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $2,875.00 | 2023 | |
| Hologic INC | $2,250.00 | 2021 | |
| Genentech, INC. | $2,192.95 | 2025 | |
| Eli Lilly and Company | $1,681.46 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $1,446.00 | 2021 | |
| Janssen Research & Development, LLC | $620.00 | 2022 | |
| Foundation Medicine, INC. | $29.04 | 2021 | |
| Janssen Biotech, INC. | $19.03 | 2025 | Rybrevant |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.